# Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

> **NCT05838053** · — · RECRUITING · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 446 (estimated)

## Conditions studied

- Lung Adenocarcinoma

## Interventions

- **PROCEDURE:** Lobectomy with systemic lymph node dissection
- **PROCEDURE:** Segmentectomy with systemic lymph node dissection

## Key facts

- **NCT ID:** NCT05838053
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-20
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 446 (ESTIMATED)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05838053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05838053, "Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05838053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*